Top Markets
Coin of the day
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
주식 순위 #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
주가
$3.86
시가총액
$21.49M
변동 (1일)
-0.17%
변동 (1년)
-25.27%
국가
JP
거래 Human Metabolome Technologies, Inc. (6090)

카테고리

Human Metabolome Technologies, Inc. (6090)의 주식 분할 이력
Human Metabolome Technologies, Inc. 주식 (심볼: 6090)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 19, 2026에 발생했습니다.
Aug 19, 2026 이전에 매수한 6090 주식 1주는 현재 0주의 6090 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH